Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2022

View Archived Issues

Fgg-impaired zebrafish present dysfibrinogenemia

PDE5A targeting enhances chemotherapy efficacy in esophageal adenocarcinoma

Amylyx sponsors research at SRI on Bax and Bak inhibitors for ALS and neurodegenerative diseases

Novel orally active NLRP3 inflammasome inhibitor alleviates DSS-induced colitis in mice

Medshine Discovery patents IRAK4 and BTK inhibitors

Inventiosbio discloses new TYK2 inhibitors

Abbisko Therapeutics describes new GTPase KRAS inhibitors

Jiangsu Tasly Diyi Pharmaceutical presents new FXR agonists

Chinese researchers synthesize new vasopressin receptor antagonists

Targeting GABA-transported GAT-3 in astrocytes reduces negative outcomes of brain injury

Organoid efficacy data leads to approval of clinical trial of rare disease drug

Researchers unveil novel markers involved in pulmonary embolism

Novel HDAC3 inhibitor shows antitumor activity in 4T1-Luc xenograft mouse model

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...